PAM
LGND icon

Paradigm Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Paradigm Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,366
Closed -$236K – 439
2022
Q1 		$236K Hold
3,366
– – 0.06% 279
2021
Q4 		$324K Sell
3,366
-481
-13% -$44.4K 0.08% 266
2021
Q3 		$334K Sell
3,847
-481
-11% -$37.2K 0.09% 274
2021
Q2 		$354K Sell
4,328
-321
-7% -$26.7K 0.09% 286
2021
Q1 		$442K Sell
4,649
-481
-9% -$45.5K 0.12% 269
2020
Q4 		$318K Buy
+5,130
New +$292K 0.09% 303
2017
Q2 		– Sell
-806
Closed -$53.2K – 622
2017
Q1 		$53.2K Sell
806
-1,683
-68% -$111K 0.01% 569
2016
Q4 		$158K Sell
2,489
-4,809
-66% -$303K 0.03% 315
2016
Q3 		$465K Sell
7,298
-1,924
-21% -$141K 0.08% 263
2016
Q2 		$686K Buy
9,222
+160
+2% +$11.9K 0.12% 156
2016
Q1 		$605K Sell
9,062
-3,842
-30% -$234K 0.11% 194
2015
Q4 		$873K Sell
12,904
-2,725
-17% -$168K 0.15% 123
2015
Q3 		$835K Buy
+15,629
New +$948K 0.11% 201

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Paradigm Asset Management's LGND Position: Q2 2022 in Review

Paradigm Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q2 2022, closing a stake of 3,366 shares — an estimated $236K sold.

Paradigm Asset Management first reported a position in LGND in Q3 2015 and held it in 13 quarters. The position peaked at $873K in Q4 2015. 197 funds tracked by Wall St. Rank hold LGND as of Q2 2022.

  • Paradigm Asset Management reported no remaining Ligand Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Paradigm Asset Management sold 3,366 Ligand Pharmaceuticals shares in Q2 2022, an estimated $236K.
  • Paradigm Asset Management first reported a position in Ligand Pharmaceuticals in Q3 2015 and held it in 13 quarters.
  • Paradigm Asset Management's Ligand Pharmaceuticals position peaked at $873K in Q4 2015.
  • 197 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2022.

Based on Paradigm Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.